Inactive Instrument

Sector Chart Salix Pharmaceuticals, Ltd.

Equities

US7954351067

"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Specialty & Advanced Pharmaceuticals

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
79.03B
8.78B
4.83B
4.65B - -
3.89B